Results 211 to 220 of about 52,437 (273)
Some of the next articles are maybe not open access.

Takayasu Arteritis

Mayo Clinic Proceedings, 2023
Fatima M, Ezzeddine   +2 more
semanticscholar   +4 more sources

Management of Takayasu arteritis.

Baillière's Best Practice & Research : Clinical Rheumatology, 2023
This review overviews the challenges in the assessment of disease activity, damage, and therapy of Takayasu arteritis (TAK). Recently developed disease activity scores for TAK are more useful for follow-up visits and require validation of cut-offs for ...
D. Misra   +6 more
semanticscholar   +1 more source

Development of the Takayasu Arteritis Integrated Disease Activity Index

Arthritis care & research, 2023
Accurate clinical assessment of disease activity in Takayasu arteritis (TAK) can be challenging. 18F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) can directly measure vascular inflammation. This study details the development of a new type of
C. Marvisi   +14 more
semanticscholar   +1 more source

Updates in the diagnosis and management of Takayasu’s arteritis

Postgraduate medicine, 2023
Takayasu’s arteritis is a rare, chronic, large vessel vasculitis which affects the aorta and its large branches. Early diagnosis is important to prevent serious end organ damage, including to stroke and ischemic heart disease.
A. Somashekar, Y. T. Leung
semanticscholar   +1 more source

Alterations of Gut Microbiome, Metabolome, and Lipidome in Takayasu Arteritis

Arthritis & Rheumatology, 2022
Mounting evidence has linked microbiome and metabolome to systemic autoimmunity and cardiovascular diseases (CVDs). Takayasu arteritis (TAK) is a rare disease that shares features of immune‐related inflammatory diseases and CVDs, about which there is ...
Luyun Fan   +24 more
semanticscholar   +1 more source

Takayasu’s arteritis

Current Treatment Options in Cardiovascular Medicine, 2008
Takayasu's arteritis is a rare disease that causes arterial inflammation with resulting stenosis or aneurysm of affected vessels. It primarily affects young females and has a predilection for the aorta, its primary branches, and the pulmonary arteries.
Curry L, Koening, Carol A, Langford
openaire   +2 more sources

Takayasu’s arteritis

Current Treatment Options in Cardiovascular Medicine, 1999
Takayasu's arteritis is a worldwide entity that requires astuteness for early diagnosis. The challenge for the practicing physician is to document active disease, not only to justify immunosuppressive therapy but also to determine the appropriate timing for surgical intervention.
, Mohan, , Kerr
openaire   +2 more sources

Takayasu arteritis

Current Opinion in Rheumatology, 2015
Open and endovascular surgery remains important in the management of Takayasu arteritis. This review summarizes the indications and approaches available, the evidence for them and recent advances.The outlook in Takayasu arteritis has improved over the last decade, reflecting earlier diagnosis, increased use of noninvasive imaging and combination ...
Richard A. Watts   +2 more
openaire   +3 more sources

Takayasu’s arteritis

Current Rheumatology Reports, 2002
The frequency of Takayasu's arteritis (TA) has been estimated to be 2.9 cases per 1 million people, with a female preponderance, although female-to-male ratio varies from different geographic areas. A high frequency of haplotype A24-B52-DR2 has been found in Japanese patients, without this association in other populations.
Antonio, Fraga, Francisco, Medina
openaire   +2 more sources

Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis

Annals of the Rheumatic Diseases, 2020
Takayasu arteritis (TAK) is a form of large vessel vasculitis resulting in thickening and stenosis of the large-sized arteries, particularly the aorta and its main branches.
Saki Kuwabara   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy